Shifu Mo

Title: Shifu Mo: Innovator in Biopharmaceuticals

Introduction

Shifu Mo is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for tumors and viral infections. With a total of 2 patents, his work is paving the way for advancements in medical therapies.

Latest Patents

Shifu Mo's latest patents include a fusion protein and its application in preparing medicine for treating tumors and/or viral infections. This patent provides a fusion protein and methods for preparing a pharmaceutical composition that includes the fusion protein. The fusion protein specifically binds to human OX40 and a human interferon, offering a novel approach to treating tumors and viral infections. Another significant patent is for an anti-OX40 antibody, which is an isolated antibody or antigen-binding fragment that can be used to prepare a medicament for treating tumors.

Career Highlights

Shifu Mo is currently associated with Nanjing Umab-biopharma Co., Ltd., where he continues to innovate in the biopharmaceutical sector. His work focuses on developing effective treatments that leverage the body's immune response to combat diseases.

Collaborations

Shifu Mo collaborates with notable colleagues, including Yong Zhao and Wei Xu, who contribute to his research and development efforts. Their combined expertise enhances the potential for groundbreaking discoveries in the field.

Conclusion

Shifu Mo's contributions to biopharmaceuticals exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to advancing healthcare solutions for critical health challenges.